Mateos, M.-V.; Bladé, J.; Bringhen, S.; Ocio, E.M.; Efebera, Y.; Pour, L.; Gay, F.; Sonneveld, P.; Gullbo, J.; Richardson, P.G.
Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma. J. Clin. Med. 2020, 9, 3120.
https://doi.org/10.3390/jcm9103120
AMA Style
Mateos M-V, Bladé J, Bringhen S, Ocio EM, Efebera Y, Pour L, Gay F, Sonneveld P, Gullbo J, Richardson PG.
Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma. Journal of Clinical Medicine. 2020; 9(10):3120.
https://doi.org/10.3390/jcm9103120
Chicago/Turabian Style
Mateos, María-Victoria, Joan Bladé, Sara Bringhen, Enrique M Ocio, Yvonne Efebera, Luděk Pour, Francesca Gay, Pieter Sonneveld, Joachim Gullbo, and Paul G. Richardson.
2020. "Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma" Journal of Clinical Medicine 9, no. 10: 3120.
https://doi.org/10.3390/jcm9103120
APA Style
Mateos, M.-V., Bladé, J., Bringhen, S., Ocio, E. M., Efebera, Y., Pour, L., Gay, F., Sonneveld, P., Gullbo, J., & Richardson, P. G.
(2020). Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma. Journal of Clinical Medicine, 9(10), 3120.
https://doi.org/10.3390/jcm9103120
